We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Considerations for Randomizing 1 Eye or 2 Eyes—Reply

Adam R. Glassman, MS1; Michele Melia, ScM1
[+] Author Affiliations
1Jaeb Center for Health Research, Tampa, Florida
JAMA Ophthalmol. 2015;133(10):1221. doi:10.1001/jamaophthalmol.2015.2759.
Text Size: A A A
Published online


In Reply We agree with Bunce and Wormald that all important information regarding an individual’s participation in a trial including the option of enrolling 1 or both eyes and whether the eyes will receive different treatments if both are enrolled must be explained in the informed consent form and discussed with the individual. To our knowledge, in Diabetic Retinopathy Clinical Research Network trials, enrolling both eyes has not been an issue from the participant’s perspective. To Bunce and Wormald’s second point, we noted in our article that patient-level outcomes such as quality of life cannot be interpreted when one eye receives one treatment and the other eye receives another treatment.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





October 1, 2015
Catey Bunce, DSc; Richard Wormald, FRCOphth
1National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, England2Cochrane Eyes and Vision Group, London School of Hygiene and Tropical Medicine, London, England
JAMA Ophthalmol. 2015;133(10):1221. doi:10.1001/jamaophthalmol.2015.2757.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...